As we look forward to 2019, the hospital/health system M&A market is increasingly becoming a bifurcated landscape of clear “haves” and “have-nots”.
In November, healthcare information technology companies hit end-of-year numbers rivaling those of the long-term care, physician practice, and health and hospital system sectors.
Despite the uncertainty and ambiguity that define the current healthcare landscape, many nontraditional players have been tempted by the substantial opportunities available in the healthcare market. Take a look at six of the most important entrants into the healthcare market in 2018.
Overall, nine hospital–health system deals were announced in October. Notably, a deal between Dallas-based Baylor Scott & White Health and Houston-based Memorial Hermann Health System was announced on October 1, and two deals were announced by Cleveland Clinic.
In Q3, the long-term care sector led with 69 transactions announced or closed, the most of any healthcare segment tracked by investment bankers.
Private equity investment is burgeoning throughout the U.S., and health care is one of the “in” targets for investors.
The first half of 2018 saw a strong wave of M&A and dealmaking activity across nearly all sectors of the US healthcare industry. The second half of 2018 likely will be just as robust.
A revolution in collaboration models is fundamentally changing the business of healthcare. In an effort to lower costs and expand access—and maybe to avoid antitrust laws—partnerships between seemingly unlikely and even unrelated organizations are becoming the norm. Is it also true in the public health world, where issues with costs and access can prevent care delivery to those who may need it most?
In this Q&A, meet Hector Torres: a former investment banker, an M&A lawyer, and a healthcare consultant. Learn how Hector’s robust background helps him provide multifaceted solutions for clients.
Page 1 of 8